Amifostine Injection USP 500 mg | Global Oncology Supportive Care Medicine Supplier

Product Introduction

Amifostine Injection USP 500 mg is a prescription cytoprotective (protective) medicine used in oncology to help reduce certain side effects associated with chemotherapy and radiation therapy. It is administered by trained healthcare professionals before cancer treatment in selected patients. Ernest Oncology supplies export-quality Amifostine Injection USP 500 mg to licensed pharmaceutical importers, oncology hospitals, government procurement agencies, and international healthcare distributors.

Technical Product Information

How Amifostine Works in the Body

After intravenous administration, Amifostine is rapidly converted by normal tissues into an active metabolite. This active compound helps protect healthy cells from damage caused by chemotherapy and radiation while allowing cancer treatment to continue as planned. The protective effect is greater in normal tissues than in tumor tissues because normal cells activate the medicine more efficiently.

Mechanism of Action

Amifostine acts as a cytoprotective agent by scavenging harmful free radicals generated during chemotherapy or radiation therapy. It also donates hydrogen ions that help reduce DNA damage in healthy tissues, thereby lowering treatment-related toxicity without significantly reducing the effectiveness of anticancer therapy.

Who Can Use Amifostine Injection?

This medicine may be prescribed by oncology specialists for selected patients undergoing cancer treatment.

Common clinical uses include:

• Patients receiving platinum-based chemotherapy
• Patients undergoing radiation therapy for head and neck cancers
• Individuals requiring protection of healthy tissues during cancer treatment
• Adults considered appropriate candidates by their treating oncologist

The decision to use Amifostine depends on the patient's medical condition and overall treatment plan.

Recommended Dosage

Dosage varies depending on the chemotherapy or radiation protocol.

General recommendations include:

• Administered only by trained healthcare professionals.
• Given intravenously before chemotherapy or radiation therapy.
• Dose is determined according to treatment indication, body surface area, and clinical condition.
• Blood pressure should be monitored during administration.

Patients should never self-administer this medicine.

Precautions

Before administration, healthcare providers should:

• Evaluate hydration status.
• Monitor blood pressure before, during, and after infusion.
• Review kidney function and overall health.
• Assess for previous allergic reactions to Amifostine.
• Inform patients about possible temporary blood pressure changes.
• Continue regular oncology monitoring throughout treatment.

Possible Side Effects

Common Side Effects

• Nausea
• Vomiting
• Temporary low blood pressure
• Flushing
• Dizziness
• Hiccups
• Mild skin rash

Serious Side Effects

• Severe hypotension
• Allergic reactions
• Difficulty breathing
• Cardiac complications
• Severe skin reactions

Immediate medical intervention is required if severe allergic reactions or significant blood pressure changes occur.

Safety Information

Safe administration requires:

• Hospital or oncology clinic administration only.
• Monitoring by qualified healthcare professionals.
• Adequate hydration before treatment.
• Blood pressure monitoring during infusion.
• Immediate discontinuation if severe hypersensitivity develops.
• Routine follow-up according to oncology treatment protocols.

Storage & Handling

To preserve product quality:

• Store according to the manufacturer's labeled storage conditions.
• Protect from excessive heat and direct sunlight.
• Store in the original packaging until use.
• Reconstitute only according to approved clinical guidelines.
• Use aseptic handling techniques during preparation.
• Dispose of unused product following local medical waste regulations.

Why Choose Indian Pharmaceutical Exports?

India has become a preferred sourcing destination for oncology supportive care medicines because of its strong pharmaceutical manufacturing ecosystem.

Benefits for International Buyers

• WHO-GMP-certified manufacturing facilities
• International quality standards
• Reliable production capacity
• Competitive export pricing
• Experienced global logistics support
• Batch-to-batch quality consistency
• Established export network
• Efficient procurement for institutional buyers

Export Documentation

Ernest Oncology supports international buyers by providing documentation required for pharmaceutical imports, subject to destination-country regulations.

Documentation may include:

• Certificate of Analysis (COA)
• Commercial Invoice
• Packing List
• Batch Manufacturing Record
• Product Specification Sheet
• Certificate of Origin (where applicable)
• Manufacturing License Details
• Export Compliance Documentation
• Additional regulatory documents upon request

Why International Buyers Choose Ernest Oncology

Our oncology export services are built to support reliable pharmaceutical procurement.

Our Strengths

• WHO-GMP manufacturing partners
• Stable bulk supply capability
• Export-compliant packaging
• Competitive wholesale pricing
• Batch-wise quality assurance
• Professional export documentation
• Dedicated logistics coordination
• Long-term procurement support
• Responsive international customer service
• Worldwide distribution network

Industries We Supply

We work with:

• Pharmaceutical Importers
• Oncology Medicine Distributors
• Hospital Procurement Departments
• Cancer Treatment Centers
• Government Healthcare Organizations
• International Pharmaceutical Wholesalers
• Specialty Oncology Pharmacies
• Licensed Medical Supply Companies

Short SEO Blog

Amifostine Injection USP 500 mg – Trusted Cytoprotective Medicine for Global Oncology Procurement

Amifostine Injection USP 500 mg plays an important role in supportive cancer care by helping reduce certain treatment-related toxicities associated with chemotherapy and radiation therapy. International pharmaceutical buyers require dependable suppliers capable of providing consistent quality, regulatory documentation, and efficient export services. Ernest Oncology supplies export-quality Amifostine Injection manufactured in WHO-GMP-compliant facilities with reliable international logistics, making us a trusted procurement partner for hospitals, distributors, and healthcare organizations worldwide.

Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites

www.ernestimpex.com

www.ernestvision.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

📧 Corporate Email
exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

🔗 Live WhatsApp Chat: https://wa.me/919359902383